Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lin Bioscience

Lin Bioscience?uq=UG6efJS6
2016 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
6696 STOCK SYMBOL
$1.31 SHARE PRICE (As of Friday Closing)
Description

Operator of a drug development company intended to specialize in the development of innovative drug treatments for diseases with unmet medical needs. The company's drug development line of medicines include LBS-008, oral small molecular drug candidate, to target Dry AMD and Stargardt Disease in Ophthalmology indications also development of CDC7 inhibitor, LBS-007, for the treatment of hard to treat cancers, such as in acute leukemia's, pancreatic cancer and ovarian cancer indications, enabling patients to treat life-threatening or disabling diseases in Oncology, Ophthalmology and Cardiovascular indications.

Ownership Status
Publicly Held
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
ROCO
Primary Office
  • 12 Floor, No.68, Sector 5
  • Zhongxiao East Road, Xinyi District
  • Taipei, 110
  • Taiwan
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lin Bioscience’s full profile, request a free trial.

Lin Bioscience Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.22 - $1.58 $83.2M $1.40 305K 59.5M

Lin Bioscience Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 0 6
EBITDA (4,673) (5,195) (1,308)
Net Income (4,298) (5,219) (1,302)
Total Assets 15,804 18,279 16,228
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lin Bioscience Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Lin Bioscience‘s full profile, request access.

Request full access to PitchBook

Lin Bioscience Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Lin Bioscience‘s full profile, request access.

Request full access to PitchBook

Lin Bioscience Executive Team (2)

Name Title Board
Seat
Contact
Info
Tom Lin Ph.D Founder, Chairman & Chief Executive Officer
Irene Wang Ph.D President & Director, Research & Development

Lin Bioscience Board Members (1)

Name Representing Role Since Contact
Info
Tom Lin Ph.D Lin Bioscience Founder, Chairman & Chief Executive Officer 000 0000